查找临床试验
已按「皮肌炎」检索，对应国际通用词 dermatomyositis
共找到 12 项正在招募的试验（在欧美日韩等发达国家设有中心）
数据更新于 11:18，每 5 分钟自动同步Identification of Cutaneous and Blood Biomarkers Predictive of Response to Systemic Treatments During Chronic Inflammatory Skin Diseases
France
年龄 18 Years – 不限
Assistance Publique - Hôpitaux de Paris
FAST for DM - Fatty Acid Supplementation Trial (FAST) for Dermatomyositis (DM)
United States
年龄 18 Years – 60 Years
National Institute of Environmental Health Sciences (NIEHS)
A Study to Understand How the Study Medicine Dazukibart Works in People With Idiopathic Inflammatory Myopathies
United States、Argentina、Bulgaria、China、Hungary 等 12 国
年龄 18 Years – 不限
Pfizer
Clinical Responsiveness of Dermatomyositis Using Cutaneous Dermatomyositis Disease Area and Severity Index (CDASI)
United States
年龄 18 Years – 不限
University of Pennsylvania
Safety and Efficacy of ULSC on Disease Severity and Steroid Tapering in Participants With Dermatomyositis/ Polymyositis (DM/PM), Also Known as Idiopathic Inflammatory Myopathy (IIM)
United States
年龄 18 Years – 不限
Restem, LLC.
Phase 1b Trial of RAY121 in Immunological Diseases (RAINBOW Trial)
United States、Australia、Austria、Bulgaria、Canada 等 12 国
年龄 18 Years – 85 Years
Chugai Pharmaceutical
Home Based Clinical Management of Interstitial Lung Disease in Systemic Rheumatic Diseases
Norway
年龄 18 Years – 不限
Oslo University Hospital
Subcutaneous Injection of Sodium Thiosulfate for Ectopic Calcifications or Ossifications. A Pilot Study
France
年龄 6 Months – 不限
University Hospital, Limoges
Anti-CD19 CAR T-Cell Therapy in Refractory Systemic Autoimmune Diseases
Italy
年龄 18 Years – 65 Years
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Topical Ruxolitinib Cream for Refractory Cutaneous Dermatomyositis
United States
年龄 18 Years – 89 Years
The Cleveland Clinic
Emapalumab MDA5 Rapidly Progressive Interstitial Lung Disease (RP-ILD) Study
United States
年龄 18 Years – 不限
University of Miami
A Study to Investigate the Efficacy and Safety of Anifrolumab Administered as Subcutaneous Injection and Added to Standard of Care Compared With Placebo Added to Standard of Care in Adult Participants With Idiopathic Inflammatory Myopathies (Polymyositis and Dermatomyositis)
United States、Argentina、Australia、Austria、Belgium 等 12 国
年龄 18 Years – 75 Years
AstraZeneca